Código QR (código de barras bidimensional)

An exploration of the optimal combination chemotherapy regimen based on neoadjuvant therapy containing pyrotinib for HER2-positive breast cancer: A multicenter real-world study

Background: The combination of pyrotinib (Py) with cytotoxic agents proved to be effective in early human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). However, the optimal chemotherapy regimen is unknown. This study attempts to explore it from real-world research data. Meth...

ver descrição completa

Na minha lista:
Principais autores: Shan Wang, Zining Jin, Zhaohui Li, Guolian Zhu, Bin Liu, Dianlong Zhang, Shuhong Tang, Fan Yao, Jian Wen, Yi Zhao, Xiaolan Wang, Feng Jin, Jia Wang
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2025-01-01
coleção:Translational Oncology
Assuntos:
Pyrotinib
Neoadjuvant therapy
Breast cancer
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S1936523324002997
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados